Deep Medicine (DMAQ) Closes TruGolf Deal
by Marlena Haddad on 2024-01-31 at 5:13pm

Deep Medicine (NASDAQ:DMAQ) has closed its combination with golf simulator company TruGolf and will begin trading on The Nasdaq under the new ticker symbol “TRUG” on February 1.

The deal and all other proposals were previously approved by shareholders at a special meeting held on January 19.

In connection with the vote, shareholders of 378,744 DMAQ’s public shares opted to redeem their shares. Including prior votes, DMAQ shareholders redeemed an aggregate of 98.5% of the trust, leaving the SPAC with $2,254,230 and 196,020 shares remaining.

Deep Medicine announced its $125 million deal with TruGolf in April 2023. It previously planned to combine with Chinese carmaker Chijet, but the deal was terminated in September 2022. Centerville, Utah-based TruGolf manufactures advanced golf simulators and launch monitors for both home entertainment and commercial uses.

TruGolf’s current management team will continue to lead the combined company following the closing.


  • I-Bankers Securities, Inc. acted as sole bookrunner for the DMAQ IPO and served as financial advisor to DMAQ.
  • ArentFox Schiff LLP and Sichenzia Ross Ference Carmel LLP served as counsel to TruGolf.
  • Ellenoff Grossman & Schole LLP served as counsel to DMAQ.
Recent Posts
by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

by Nicholas Alan Clayton on 2024-04-16 at 7:58am

At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...

by Nicholas Alan Clayton on 2024-04-15 at 3:47pm

AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...

by Nicholas Alan Clayton on 2024-04-15 at 9:35am

Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...


Copyright © 2023 SPACInsider, Inc. All Rights Reserved